Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Humira for the Treatment of Hidradenitis Suppurativa

Drug Name

Humira (adalimumab)

Developer

AbbVie

Therapy Class

Monoclonal antibody

Product Description

Tumour necrosis factor (TNF) inhibitor

Current Indication

Rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis

Market Sector

Rheumatology

Development Status

Approved in the US, Europe, Japan, and China
Expand
Close
Close
Close

Go Top